by CheckRare Staff | Dec 15, 2022
Can Ficicioglu, MD, PhD, Clinical Director of the Metabolic Disease Program at Children’s Hospital of Philadelphia (CHOP), discusses the management of homocystinuria. Homocystinuria is a rare congenital metabolic disease characterized by extremely...
by CheckRare Staff | Dec 14, 2022
Ajai Chari, MD, Professor of Medicine and Director of Clinical Research, Multiple Myeloma Program, Mount Sinai School of Medicine, discusses results from the phase 1/2 MonumenTAL-1 clinical trial. These results were recently presented at this year’s American...
by CheckRare Staff | Dec 1, 2022
Bonnie Smeryage, NP, Pediatric Nurse Practitioner in Hollywood, FL, discusses the benefits of liquid formulations in pediatric populations. Pediatric medication nonadherence is a major challenge for health care providers. Many patients do not take their...
by CheckRare Staff | Nov 28, 2022
Sean J. Pittock, MD, Director of Mayo Clinic’s Center for Multiple Sclerosis and Autoimmune Neurology and of Mayo’s Neuroimmunology Laboratory discusses the latest results from Phase III CHAMPION-NMOSD trial recently presented at European Committee...
by CheckRare Staff | Nov 15, 2022
Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with Dravet syndrome. As Dr. Ticho explains, Dravet syndrome is a rare neurological condition that usually...
